Market Chatter: Evotec Attracts Potential Takeover Bid From Triton Partners; Shares Up

MT Newswires Live11-12

Evotec (EVO) shares were rallying Monday after Bloomberg reported that the company is the subject of a potential takeover bid by Triton Partners as the private equity firm has become one of the drug developer's largest shareholders.

Triton recently increased its stake in Evotec to 9.99%, and would require foreign investment approval to hold 10% or more. Any significant acquisition would also need backing from Evotec's major shareholders, including Novo Holdings and Mubadala Investment, Bloomberg said.

Discussions are still ongoing, and Triton may choose not to make a formal offer, according to people familiar with the matter.

Both companies didn't immediately respond to a request for comment from MT Newswires.

Shares of Evotec were up 18% in recent Monday trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 4.88, Change: +0.75, Percent Change: +18.04

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2482875931?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-12 02:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482875931","market":"sg","top_or_hot":-1,"title":"Market Chatter: Evotec Attracts Potential Takeover Bid From Triton Partners; Shares Up","media":"MT Newswires Live","content":"<html><body><p> Evotec (EVO) shares were rallying Monday after Bloomberg reported that the company is the subject of a potential takeover bid by Triton Partners as the private equity firm has become one of the drug developer's largest shareholders.</p><p>Triton recently increased its stake in Evotec to 9.99%, and would require foreign investment approval to hold 10% or more. Any significant acquisition would also need backing from Evotec's major shareholders, including Novo Holdings and Mubadala Investment, Bloomberg said.</p><p>Discussions are still ongoing, and Triton may choose not to make a formal offer, according to people familiar with the matter.</p><p>Both companies didn't immediately respond to a request for comment from MT Newswires.</p><p>Shares of Evotec were up 18% in recent Monday trading.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p><p>Price: 4.88, Change: +0.75, Percent Change: +18.04</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Chatter: Evotec Attracts Potential Takeover Bid From Triton Partners; Shares Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Chatter: Evotec Attracts Potential Takeover Bid From Triton Partners; Shares Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-12 02:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Evotec (EVO) shares were rallying Monday after Bloomberg reported that the company is the subject of a potential takeover bid by Triton Partners as the private equity firm has become one of the drug ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVO.AU","symbol_name":"EMBARK EARLY EDUCATION LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2482875931","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482875931","pubTimestamp":1731349789,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Evotec (EVO) shares were rallying Monday after Bloomberg reported that the company is the subject of a potential takeover bid by Triton Partners as the private equity firm has become one of the drug d","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVO.AU":"EMBARK EARLY EDUCATION LTD","BK7132":"教育服务","EVO":"Evotec SE","BK4121":"生命科学工具和服务","TRTN":"Triton International Limited","BK4104":"贸易公司与经销商"},"translate_title":"市场热议：Evotec吸引了Triton Partners的潜在收购要约；股票上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVO.AU":1,"TRTN":1,"EVO":0.9},"content_text":"Evotec (EVO) shares were rallying Monday after Bloomberg reported that the company is the subject of a potential takeover bid by Triton Partners as the private equity firm has become one of the drug developer's largest shareholders.Triton recently increased its stake in Evotec to 9.99%, and would require foreign investment approval to hold 10% or more. Any significant acquisition would also need backing from Evotec's major shareholders, including Novo Holdings and Mubadala Investment, Bloomberg said.Discussions are still ongoing, and Triton may choose not to make a formal offer, according to people familiar with the matter.Both companies didn't immediately respond to a request for comment from MT Newswires.Shares of Evotec were up 18% in recent Monday trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 4.88, Change: +0.75, Percent Change: +18.04","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482875931"}